Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.3K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.5K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

616
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
616
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

5.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.7K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

434
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abiraterone-Induced Hypokalemia and Hypophosphatemia: A Case Report.

Cureus·2026
Same author

Fludrocortisone for Refractory Hypotension in a Hospitalized Dialysis Patient: A Case Report.

Cureus·2025
Same author

Unusual Presentation of Cryptococcal Meningitis in an Immunocompetent Patient on Hemodialysis.

Cureus·2025
Same author

A Challenging Case of Weil's Syndrome in New York City: A Short Review of the Renal Pathophysiology and Diagnosis of Leptospirosis.

Cureus·2025
Same author

A Rare Case of Seronegative Lupus Nephritis Presenting as Immune Complex Diffuse Glomerulonephritis.

Cureus·2025
Same author

Collapsing Focal Segmental Glomerulosclerosis With Concurrent IgG4 Nephropathy.

Cureus·2025

Related Experiment Video

Updated: Mar 8, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.2K

What Do We Know about Opioids and the Kidney?

Mary Mallappallil1, Jacob Sabu2, Eli A Friedman3

  • 1Department of Internal Medicine, State University of New York at Downstate, Brooklyn, New York, NY 11203, USA. marynephrology@yahoo.com.

International Journal of Molecular Sciences
|January 25, 2017
PubMed
Summary

Opioid use is linked to kidney disease, causing acute and chronic kidney injury. This review examines opioid effects on renal function, considering safe use and toxicity risks amid rising global consumption.

Keywords:
opioidspharmacokineticsrenal failure

More Related Videos

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

41.0K
Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

1.7K

Related Experiment Videos

Last Updated: Mar 8, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.2K
Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

41.0K
Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

1.7K

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Growing global use of opioids for medical and recreational purposes necessitates understanding their impact on kidney health.
  • Opioid use is increasingly associated with adverse renal outcomes.
  • Existing literature on opioid-induced nephrotoxicity requires comprehensive synthesis.

Purpose of the Study:

  • To review the renal manifestations associated with opioid use.
  • To explore the direct and indirect effects of opioids on kidney injury.
  • To discuss the safe use of opioids in patients with pre-existing kidney disease and address toxicity concerns.

Main Methods:

  • Systematic literature review of studies investigating opioid use and kidney disease.
  • Analysis of evidence on acute kidney injury (AKI) and chronic kidney disease (CKD) related to opioids.
  • Examination of pharmacological and contextual factors contributing to renal failure.

Main Results:

  • Opioid use is associated with various renal manifestations, including acute and chronic kidney injury.
  • Both direct drug toxicity and indirect effects (e.g., rhabdomyolysis, infections) contribute to kidney damage.
  • Opioids can be used safely for pain management in patients with kidney disease, but careful monitoring for side effects is crucial.

Conclusions:

  • Opioid-induced nephrotoxicity is a significant concern, particularly with increased global usage.
  • Understanding the mechanisms of renal injury is vital for mitigating risks.
  • Balancing the benefits of opioid analgesia with potential renal toxicity is essential for patient care.